These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36660014)

  • 1. Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis.
    Dhoot D; Jain GK; Manjhi M; Kesharwani P; Mahadkar N; Barkate H
    Drugs Context; 2023; 12():. PubMed ID: 36660014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Open-Label, Randomized, Double-Arm Clinical Trial to Compare the Effectiveness and Safety of Super Bioavailable Itraconazole Capsules and Itraconazole Capsules in the Management of Dermatophytosis in India.
    Shenoy M; Dhoot D; Mahajan H; Barkate H
    Clin Cosmet Investig Dermatol; 2021; 14():1367-1376. PubMed ID: 34611418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial.
    Shenoy MM; De A; Shah B; Das A; Saraswat A; Lahiri K; Yadav S; Sarda A; Chakraborty D; J D; Kamat S; Doshi Y; Gonsalves N; Choudhary A; Dhoot D; Mahadkar N; Bhushan S; Gadkari R; Barkate H
    Drug Des Devel Ther; 2023; 17():2899-2908. PubMed ID: 37766823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Use of Super-Bioavailable Itraconazole for the Management of Dermatophytosis: Consensus Statement by Dermatologists from India via the Modified Delphi Technique.
    Saraswat A; Dogra S; Shenoy M; Verma S; K S; Ghate S; Ganjoo A; Aurangabadkar S; Tiwari A; Poojary S; Inamdar A; Majid I; Girdhar M; Shah B; Varma S; Ramamoorthy R; Dhoot D; Barkate H
    Dermatology; 2024; 240(4):671-683. PubMed ID: 38697027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Optimal Dosing Regimen of Super Bioavailable Itraconazole in Obesity: An Experimental Rat Model Study.
    Jain GK; Chitnis KR; Singhal P; Mahadkar N; Dhoot D; Barkate H
    Cureus; 2023 Apr; 15(4):e37462. PubMed ID: 37187635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Efficacy of Super Bioavailable Itraconazole Capsules 50 mg vs 65 mg Twice Daily in the Management of Glabrous Tinea.
    Shah B; Mistry D; Jairam D; Kansara K; Pandya R; Vasani P; Dhoot D; Mahadkar N; Bhushan S; Barkate H
    Infect Drug Resist; 2023; 16():2409-2416. PubMed ID: 37125212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Efficacy and Safety of Super-Bioavailable Itraconazole-130 mg Once Daily in Obese and Non-Obese Patients of Glabrous Tinea.
    Shenoy M; De A; Shah B; Das A; Saraswat A; Lahiri K; Dhoot D
    Indian Dermatol Online J; 2023; 14(6):839-843. PubMed ID: 38099030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-Label Crossover Oral Bioequivalence Pharmacokinetics Comparison for a 3-Day Loading Dose Regimen and 15-Day Steady-State Administration of SUBA-Itraconazole and Conventional Itraconazole Capsules in Healthy Adults.
    Thompson GR; Lewis P; Mudge S; Patterson TF; Burnett BP
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32457106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IADVL SIG Recalcitrant Dermatophytosis Position Statement on Super Bioavailable Itraconazole.
    Patel NH; Sardana K; Shenoy MM; Rengasamy M; Khurana A; Ghate S; Venkata CK; Marfatiya Y; Bhunia D; Jayaraman J; Das A; Jain AK
    Indian Dermatol Online J; 2024; 15(1):1-7. PubMed ID: 38283009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Super Bioavailable Itraconazole and Its Place and Relevance in Recalcitrant Dermatophytosis: Revisiting Skin Levels of Itraconazole and Minimum Inhibitory Concentration Data.
    Sardana K; Mathachan SR
    Indian Dermatol Online J; 2021; 12(1):1-5. PubMed ID: 33768016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of plasma levels of itraconazole with treatment response at 4 weeks in chronic dermatophytosis: Results of a randomised controlled trial.
    Bhalavi H; Shaw D; Mehta H; Narang T; Sachdeva N; Shafiq N; Rudramurthy SM; Dogra S
    Mycoses; 2023 Apr; 66(4):281-288. PubMed ID: 36457207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) Task Force against Recalcitrant Tinea (ITART) Consensus on the Management of Glabrous Tinea (INTACT).
    Rengasamy M; Shenoy MM; Dogra S; Asokan N; Khurana A; Poojary S; Jayaraman J; Valia AR; Sardana K; Kolalapudi S; Marfatia Y; Rao PN; Bhat RM; Kura M; Pandhi D; Barua S; Kaushal V
    Indian Dermatol Online J; 2020; 11(4):502-519. PubMed ID: 32832435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of grapefruit juice on the systemic availability of itraconazole oral solution in healthy adult volunteers.
    Gubbins PO; McConnell SA; Gurley BJ; Fincher TK; Franks AM; Williams DK; Penzak SR; Saccente M
    Pharmacotherapy; 2004 Apr; 24(4):460-7. PubMed ID: 15098799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of Single-Dose SUBA-Itraconazole Compared to Conventional Itraconazole under Fasted and Fed Conditions.
    Rauseo AM; Mazi P; Lewis P; Burnett B; Mudge S; Spec A
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0013421. PubMed ID: 34031053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxy-itraconazole pharmacokinetics is similar to that of itraconazole in immunocompromised patients receiving oral solution of itraconazole.
    Mino Y; Naito T; Watanabe T; Yamada T; Yagi T; Yamada H; Kawakami J
    Clin Chim Acta; 2013 Jan; 415():128-32. PubMed ID: 23089073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of antifungal efficacy of itraconazole loaded aspasomal cream: comparative clinical study.
    Lamie C; Elmowafy E; Ragaie MH; Attia DA; Mortada ND
    Drug Deliv; 2022 Dec; 29(1):1345-1357. PubMed ID: 35506466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Adding Low-Dose Isotretinoin to Itraconazole in the Treatment of Chronic Recurrent Dermatophytosis among Sample of Iraqi Patients: An Open-Labelled Therapeutic Clinical Comparative Study.
    Alhamdi DK; Alhamdi KI
    Indian J Dermatol; 2022; 67(5):624. PubMed ID: 36865852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris: A Randomized Clinical Trial.
    Khurana A; Agarwal A; Agrawal D; Panesar S; Ghadlinge M; Sardana K; Sethia K; Malhotra S; Chauhan A; Mehta N
    JAMA Dermatol; 2022 Sep; 158(11):1269-78. PubMed ID: 36103158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of efficacy and safety of oral terbinafine and itraconazole combination therapy in the management of dermatophytosis.
    Sharma P; Bhalla M; Thami GP; Chander J
    J Dermatolog Treat; 2020 Nov; 31(7):749-753. PubMed ID: 31030594
    [No Abstract]   [Full Text] [Related]  

  • 20. Single dose and multiple dose studies of itraconazole nanoparticles.
    Vaughn JM; McConville JT; Burgess D; Peters JI; Johnston KP; Talbert RL; Williams RO
    Eur J Pharm Biopharm; 2006 Jun; 63(2):95-102. PubMed ID: 16516450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.